HAEGARDA IS THE HAE THERAPY THAT REDUCED ATTACKS BY 95%*
With HAEGARDA, HAE
attacks were reduced by
As a preventive therapy, HAEGARDA can effectively reduce the number of HAE attacks you experience.
*Median reduction in number of attacks in patients receiving 60 IU/kg of HAEGARDA vs placebo.
Use of rescue medication
was nearly eliminated by
You should always have HAE rescue medication available at all times in case of a breakthrough attack.
†Median reduction in rescue medication use in patients receiving 60 IU/kg of HAEGARDA vs placebo.
Only
per year‡ could be a reality for you
In a long-term study following patients for more than 1.4 years, HAEGARDA reduced the HAE attack rate to 1 per year.
‡Median attack rate in patients followed over an average of 1.4 years.
Talk to your doctor
about how HAEGARDA can reduce the risk of HAE attacks
GET DOCTOR DISCUSSION GUIDE EMAIL TO METREAT YOUR DISEASE,
NOT JUST YOUR SYMPTOMS
The biggest difference since taking HAEGARDA is that for the first time in my life, I have a glimpse of what normal is. That feels good.
The root cause of HAE is missing or nonworking C1 esterase inhibitor (C1-INH), a key protein in your body that controls swelling
HAE Attacks
can occur when your levels of working C1-INH are too low or not functional (nonworking)
HAEGARDA Adds
working C1-INH to your body
HAEGARDA brings your working C1-INH levels back up
and closer to normal, reducing the risk of an HAE ATTACK
In clinical studies, the most common side effects reported with HAEGARDA were injection-site reactions (pain, redness, swelling), hypersensitivity (itching and rash), dizziness, and nasal symptoms, including stuffy or runny nose and sneezing. These are not the only side effects possible with HAEGARDA.
See in more detail how HAEGARDA works
SAFETY AND EFFICACY PROVEN IN BOTH PEDIATRIC PATIENTS AND PREGNANT WOMEN
Talk to your doctor about how HAEGARDA can be an effective and safe therapy for children
- HAEGARDA is approved for use in children 6 years of age and older
- The safety and effectiveness of HAEGARDA were evaluated in subgroups within both short- and long-term clinical trials. These subgroups, part of the larger studies, consisted of nine patients, 8 to <17 years of age. Results within this age group were consistent with overall study results
See checklists that can help you navigate HAE throughout specific stages of life
DOWNLOAD NOW
Before taking any HAE therapies, consult with your doctor if you are pregnant or considering becoming pregnant
- In a long-term study, four pregnant women with type I HAE and ranging in age from 19 to 32 years received HAEGARDA. These women received 40-60 IU/kg per subcutaneous administration for 4-8 weeks (9-15 doses) during the first trimester. These women reported no complications during delivery and all women delivered healthy babies¶
Please refer to section 8 of the prescribing information for additional data on the use of C1-INH during pregnancy and lactation.
¶ Due to study protocols, these patients were not eligible to continue the trial beyond the first trimester.
Women often experience HAE different than men do
UNDERSTAND WHYThe World Allergy Organization Recommends C1-INH as the Preferred Therapy During Pregnancy and Adolescence.
Committed to Quality Manufacturing
We understand that you want the medications you take to meet the highest safety and quality standards. That's why HAEGARDA goes through an advanced screening and purification process to reduce the risk of transmitting infection.
We are committed to producing high-quality, safe, and effective medicines. To us, that means that each step of the manufacturing process must meet or exceed the most stringent international standards for product safety in accordance with regulatory agencies worldwide.§
§The risk of transmission of infectious agents cannot be completely eliminated.
Our commitment includes:
Providing a consistent supply of HAEGARDA to all patients who start on HAEGARDA
Having in-place systems of collection, manufacturing, and distribution that meet high quality and safety standards
Producing high-quality, safe, and effective biotherapies with no confirmed transmissions of viruses with C1-INH therapies in the US
Our manufacturing process includes:
READY TO TALK WITH YOUR DOCTOR?
We want to make sure you have what you need to have a productive conversation with your doctor about HAE and about HAEGARDA.
Start the discussion off right
Be prepared and ask the right questions. Use this Doctor Discussion Guide to help you get started and to ensure you cover all the points you need during your visit.
GET DOCTORDISCUSSION GUIDE
Ready to take HAEGARDA?
Did your doctor determine that HAEGARDA was right for you? Print out this prescription
form and bring it with you to your next appointment.
PRESCRIPTION FORM